Hung David — SEC Form 4 filings
SEC reporting owner CIK 1310880. 10 Form 4 filings on record with FilingPulse; latest filed 2026-06-05.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-03-04 to 2026-06-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 2 filings — 1,000,000 shares, $1,713,720 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 3,944 shares, $63,724 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: purchase of 500,000 shares @ $1.79 ($893,500) in Nuvation Bio Inc., filed 2025-06-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Nuvation Bio Inc. (NUVB) | PRESIDENT AND CEO, Director, 10% owner | 5 | 3 legs · 1,000,000 sh · $1,713,720 | — | 3 |
| NovoCure Ltd (NVCR) | Director | 5 | — | 2 legs · 3,944 sh · $63,724 | 6 |
Form 4 filings — Hung David
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-05 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 11,610 @ $0 · Grant/award (A): 16,999 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | NovoCure Ltd (NVCR) | Sale (S): 2,945 @ $15.77 | EDGAR |
| 2026-03-03 | 4 | Nuvation Bio Inc. (NUVB) | Grant/award (A): 1,995,012 (derivative) @ $0 | EDGAR |
| 2025-06-18 | 4 | Nuvation Bio Inc. (NUVB) | Purchase (P): 500,000 @ $1.79 | EDGAR |
| 2025-06-06 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 11,215 @ $0 · Grant/award (A): 16,697 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | NovoCure Ltd (NVCR) | Sale (S): 999 @ $17.30 | EDGAR |
| 2025-04-08 | 4 | Nuvation Bio Inc. (NUVB) | Purchase (P): 200,000 @ $1.66 · Purchase (P): 300,000 @ $1.62 | EDGAR |
| 2025-03-04 | 4 | Nuvation Bio Inc. (NUVB) | Grant/award (A): 2,000,000 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 4,053 @ $0 · Grant/award (A): 6,229 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | Nuvation Bio Inc. (NUVB) | Grant/award (A): 2,000,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1310880 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →